Gaudium IVF & Women Health IPO Subscription Status and Updates
Last Updated: 25 February, 2026
4 min read
00:00 / 00:00
The Gaudium IVF & Women Health IPO has concluded with strong investor interest, achieving a final subscription of 7.27 times on its closing day, February 24, 2026. After a steady start on the opening day, the issue saw a significant surge in momentum during the final day of bidding, particularly from non-institutional and retail investors.
The company offered its shares in a price band of Rs. 75 to Rs. 79 per share, with a minimum lot size of 189 shares. The total issue size was Rs. 165.00 crore, consisting of a fresh issue of Rs. 90.00 crore and an offer for sale (OFS) of Rs. 75.00 crore.
Gaudium IVF & Women Health IPO Subscription Status - Final (Day 3)
By the end of the final bidding window, the IPO recorded oversubscription across all major categories. Non-Institutional Investors (NIIs) led the demand, booking their portion 14.05 times. The Retail segment also saw healthy participation, ending with a subscription of 7.60 times.
Category | Subscription Times |
Qualified Institutional Buyers (QIB) | 1.62x |
Non-Institutional Investors (NII) | 14.05x |
Retail Category Investors | 7.60x |
Total | 7.27x |
Last updated: 6:54 PM, Tuesday, 24 Feb 2026
Company Overview of Gaudium IVF & Women Health
Incorporated in 2015, Gaudium IVF & Women Health Ltd is a leading provider of In Vitro Fertilization (IVF) and advanced fertility treatments in India. The company operates a scalable hub-and-spoke model with 30+ locations, including 7 major hubs in cities like Delhi, Mumbai, Bengaluru, Patna, Srinagar, and Ludhiana.
Gaudium offers a comprehensive suite of services, including IVF, ICSI, IUI, genetic testing (PGT), and high-risk pregnancy management. The company is positioning itself as India's first pure-play listed fertility services platform, catering to both domestic and international patients from countries like Canada, the UK, and the USA.
Financial Performance
The company has demonstrated robust growth and high profitability. For FY25, it reported a Net Profit of Rs. 19.13 crore on a total income of Rs. 70.96 crore, representing an 85% year-on-year growth in PAT. For the first half of FY26 (H1-FY26), it recorded a profit of Rs. 12.51 crore on an income of Rs. 49.75 crore, maintaining healthy EBITDA margins of approximately 38-40%.
Also Read: Is Gaudium IVF & Women Health IPO good or bad
Strengths and Risks of Gaudium IVF & Women Health IPO
Key Strengths
Specialized Fertility Focus: India's first listed fertility-focused healthcare platform with a strong brand reputation led by founder Dr. Manika Khanna.
High Profitability: Consistent EBITDA margins of ~40%, reflecting clinical excellence and efficient operational scale.
Scalable Asset-Light Model: Uses a hub-and-spoke architecture to expand into Tier 2 and Tier 3 cities with controlled capital intensity.
Growth Potential: Plans to utilize Rs. 50 crore from the fresh issue to establish 19 new IVF centers across India.
Potential Risks
Talent Dependency: Highly dependent on a limited pool of skilled embryologists and doctors; the company has historically faced high employee attrition.
Contingent Liabilities: Significant outstanding tax disputes and legal claims (~Rs. 45 crore) relative to its net worth.
Aggressive Valuation: At the upper price band, the IPO is priced at a P/E of approximately 25-30x FY25 earnings, which some analysts view as a premium.
Success Rate Sensitivity: Revenue and reputation are tied to IVF success rates (~58%); any decline could impact patient trust.
How to Apply for Gaudium IVF & Women Health IPO
Visit the Rupeezy app or here.
Navigate to the IPO section on the Home Page
Here, you can view all the IPOs with details such as market lot, minimum bid quantity, price range, and analysis.
You can read the Red Herring Prospectus for the issue details.
Enter your UPI ID for payment & place the bid.
When placing the bid, enter the cutoff price or the desired price within the specified range. Select quantity as per lot size.
Submit to complete the order.
FAQs:
How much was the Gaudium IVF & Women Health IPO subscribed overall? The Gaudium IVF & Women Health IPO was subscribed 7.27 times by the end of the final bidding day.
What was the final subscription status of the Gaudium IVF IPO in the QIB category? The Qualified Institutional Buyers (QIB) portion of the Gaudium IVF IPO was subscribed 1.62 times.
What was the final subscription status of the Gaudium IVF IPO in the NII category? The Non-Institutional Investors (NII) category saw the highest demand, being subscribed 14.05 times.
How many times was the retail portion of the Gaudium IVF IPO subscribed? The retail investor category for the Gaudium IVF IPO recorded a subscription of 7.60 times.
Which investor category showed the most interest in the Gaudium IVF IPO? The Non-Institutional Investors (NII) category showed the most interest with a 14.05x subscription.
What is the minimum lot size to apply for the Gaudium IVF IPO? The minimum lot size for the Gaudium IVF IPO is 189 shares, requiring an investment of ?14,931.
The content on this blog is for educational purposes only and should not be considered investment advice. While we strive for accuracy, some information may contain errors or delays in updates.
Mentions of stocks or investment products are solely for informational purposes and do not constitute recommendations. Investors should conduct their own research before making any decisions.
Investing in financial markets are subject to market risks, and past performance does not guarantee future results. It is advisable to consult a qualified financial professional, review official documents, and verify information independently before making investment decisions.
All Category